Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2016, Article ID 4857917, 9 pages
http://dx.doi.org/10.1155/2016/4857917
Research Article

Association of the Aspartate Aminotransferase to Alanine Aminotransferase Ratio with BNP Level and Cardiovascular Mortality in the General Population: The Yamagata Study 10-Year Follow-Up

1Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan
2Department of Endocrinology and Metabolism, Hirosaki University Graduate School of Medicine, Aomori, Japan
3Global Center of Excellence Program Study Group, Yamagata University School of Medicine, Yamagata, Japan

Received 10 August 2016; Revised 24 September 2016; Accepted 9 October 2016

Academic Editor: Shih-Ping Hsu

Copyright © 2016 Miyuki Yokoyama et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. NIPPON DATA80 Research Group, “Risk assessment chart for death from cardiovascular disease based on a 19-year follow-up study of a Japanese representative population,” Circulation Journal, vol. 70, no. 10, pp. 1249–1255, 2006. View at Publisher · View at Google Scholar
  2. T. Tsutamoto, A. Wada, K. Maeda et al., “Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction,” Circulation, vol. 96, no. 2, pp. 509–516, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Kara, A. A. Mahabadi, M. H. Geisel et al., “B-type natriuretic peptide: distribution in the general population and the association with major cardiovascular and coronary events—the Heinz Nixdorf Recall Study,” Clinical Research in Cardiology, vol. 103, no. 2, pp. 125–132, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Kawai, M. Yoshimura, M. Harada et al., “Determination of the B-type natriuretic peptide level as a criterion for abnormalities in Japanese individuals in routine clinical practice: the J-ABS Multi-Center Study (Japan Abnormal BNP Standard),” Internal Medicine, vol. 52, no. 2, pp. 171–177, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. M. D. Samsky, C. B. Patel, T. A. DeWald et al., “Cardiohepatic interactions in heart failure: an overview and clinical implications,” Journal of the American College of Cardiology, vol. 61, no. 24, pp. 2397–2405, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. W. Deng and L. Farricielli, “Hypoxic hepatitis and acute liver failure in a patient with newly onset atrial fibrillation and diltiazem infusion,” BMJ Case Reports, vol. 2013, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. D. M. Lofthus, S. R. Stevens, P. W. Armstrong, C. B. Granger, and K. W. Mahaffey, “Pattern of liver enzyme elevations in acute ST-elevation myocardial infarction,” Coronary Artery Disease, vol. 23, no. 1, pp. 22–30, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Monami, G. Bardini, C. Lamanna et al., “Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study,” Metabolism: Clinical and Experimental, vol. 57, no. 3, pp. 387–392, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. S. A. Porter, A. Pedley, J. M. Massaro, R. S. Vasan, U. Hoffmann, and C. S. Fox, “Aminotransferase levels are associated with cardiometabolic risk above and beyond visceral fat and insulin resistance: The Framingham Heart Study,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 33, no. 1, pp. 139–146, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. V. Fuhrmann, B. Jäger, A. Zubkova, and A. Drolz, “Hypoxic hepatitis—epidemiology, pathophysiology and clinical management,” Wiener Klinische Wochenschrift, vol. 122, no. 5-6, pp. 129–139, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Henrion, “Hypoxic hepatitis,” Liver International, vol. 32, no. 7, pp. 1039–1052, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Konta, Z. Hao, H. Abiko et al., “Prevalence and risk factor analysis of microalbuminuria in Japanese general population: The Takahata Study,” Kidney International, vol. 70, no. 4, pp. 751–756, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Niizeki, Y. Takeishi, T. Arimoto et al., “Combination of heart-type fatty acid binding protein and brain natriuretic peptide can reliably risk stratify patients hospitalized for chronic heart failure,” Circulation Journal, vol. 69, no. 8, pp. 922–927, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Niizeki, Y. Takeishi, T. Arimoto et al., “Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients,” Journal of Cardiac Failure, vol. 13, no. 2, pp. 120–127, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Arimoto, Y. Takeishi, T. Niizeki et al., “Cardiac sympathetic denervation and ongoing myocardial damage for prognosis in early stages of heart failure,” Journal of Cardiac Failure, vol. 13, no. 1, pp. 34–41, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Otaki, T. Watanabe, H. Takahashi et al., “Association of heart-type fatty acid-binding protein with cardiovascular risk factors and all-cause mortality in the general population: The Takahata Study,” PLoS ONE, vol. 9, no. 5, article e94834, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Matsuo, E. Imai, M. Horio et al., “Revised equations for estimated GFR from serum creatinine in Japan,” American Journal of Kidney Diseases, vol. 53, no. 6, pp. 982–992, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Konta, S. Takasaki, K. Ichikawa et al., “The novel and independent association between single-point SNP of NPHP4 gene and renal function in non-diabetic Japanese population: The Takahata Study,” Journal of Human Genetics, vol. 55, no. 12, pp. 791–795, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. H. K. Gaggin Jr. and J. L. Januzzi, “Biomarkers and diagnostics in heart failure,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1832, no. 12, pp. 2442–2450, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. I. S. Anand, L. D. Fisher, Y.-T. Chiang et al., “Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT),” Circulation, vol. 107, no. 9, pp. 1278–1283, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Torruellas, S. W. French, and V. Medici, “Diagnosis of alcoholic liver disease,” World Journal of Gastroenterology, vol. 20, no. 33, pp. 11684–11699, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Alonso, J. R. Misialek, M. A. Amiin et al., “Circulating levels of liver enzymes and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities cohort,” Heart, vol. 100, no. 19, pp. 1511–1516, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. R. H. Christenson, H. M. E. Azzazy, S.-H. Duh, S. Maynard, S. L. Seliger, and C. R. DeFilippi, “Impact of increased body mass index on accuracy of B-type Natriuretic Peptide (BNP) and N-terminal proBNP for diagnosis of decompensated heart failure and prediction of all-cause mortality,” Clinical Chemistry, vol. 56, no. 4, pp. 633–641, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. S. R. Das, S. M. Abdullah, D. Leonard et al., “Association between renal function and circulating levels of natriuretic peptides (from the Dallas Heart Study),” The American Journal of Cardiology, vol. 102, no. 10, pp. 1394–1398, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. E. M. Koehler, D. Sanna, B. E. Hansen et al., “Serum liver enzymes are associated with all-cause mortality in an elderly population,” Liver International, vol. 34, no. 2, pp. 296–304, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. C. E. Ruhl and J. E. Everhart, “The association of low serum alanine aminotransferase activity with mortality in the us population,” American Journal of Epidemiology, vol. 178, no. 12, pp. 1702–1711, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. Z. Liu, H. Ning, S. Que, L. Wang, X. Qin, and T. Peng, “Complex association between alanine aminotransferase activity and mortality in general population: a systematic review and meta-analysis of prospective studies,” PLoS ONE, vol. 9, no. 3, article e91410, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. D. G. Le Couteur, F. M. Blyth, H. M. Creasey et al., “The association of alanine transaminase with aging, frailty, and mortality,” Journals of Gerontology—Series A Biological Sciences and Medical Sciences, vol. 65, no. 7, pp. 712–717, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. Z. Liu, S. Que, J. Xu, and T. Peng, “Alanine aminotransferase-old biomarker and new concept: a review,” International Journal of Medical Sciences, vol. 11, no. 9, pp. 925–935, 2014. View at Publisher · View at Google Scholar · View at Scopus